| Entry |
|
|---|
| Name |
Liothyronine sodium (JP18/USP);
Cytomel (TN);
Triostat (TN) |
|---|
| Product |
|
|---|
| Generic |
LIOTHYRONINE SODIUM (A-S Medication Solutions), LIOTHYRONINE SODIUM (A-S Medication Solutions), LIOTHYRONINE SODIUM (AvKARE), LIOTHYRONINE SODIUM (Biocon Pharma), LIOTHYRONINE SODIUM (Bryant Ranch Prepack), LIOTHYRONINE SODIUM (Bryant Ranch Prepack), LIOTHYRONINE SODIUM (Bryant Ranch Prepack), LIOTHYRONINE SODIUM (Bryant Ranch Prepack), LIOTHYRONINE SODIUM (Dr. Reddy's Labratories), LIOTHYRONINE SODIUM (Golden State Medical Supply), LIOTHYRONINE SODIUM (Greenstone LLC), LIOTHYRONINE SODIUM (Mayne Pharma Commercial LLC), LIOTHYRONINE SODIUM (Northstar Rx LLC), LIOTHYRONINE SODIUM (NuCare Pharmaceuticals), LIOTHYRONINE SODIUM (PD-Rx Pharmaceuticals), LIOTHYRONINE SODIUM (Preferred Pharmaceuticals), LIOTHYRONINE SODIUM (Proficient Rx LP), LIOTHYRONINE SODIUM (SIGMAPHARM LABORATORIES), LIOTHYRONINE SODIUM (Sun Pharmaceutical Industries), LIOTHYRONINE SODIUM (Teva Pharmaceuticals USA), LIOTHYRONINE SODIUM (XGen Pharmaceuticals DJB), LIOTHYRONINE SODIUM (Zydus Lifesciences Limited), LIOTHYRONINE SODIUM (Zydus Pharmaceuticals (USA)) |
|---|
| Formula |
C15H11I3NO4. Na
|
|---|
| Exact mass |
672.772
|
|---|
| Mol weight |
672.9553
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Hormonal agent
DG01953 Thyroid preparation
DG01608 Thyroid hormone replenisher
|
|---|
| Remark |
| Therapeutic category: | 2431 |
| Product (DG01372): | D01011<JP/US> |
|
|---|
| Efficacy |
Replenisher (thyroid hormone) |
|---|
| Disease |
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04919 | Thyroid hormone signaling pathway |
|
|---|
| Network |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H03 THYROID THERAPY
H03A THYROID PREPARATIONS
H03AA Thyroid hormones
H03AA02 Liothyronine sodium
D01011 Liothyronine sodium (JP18/USP) <JP/US>
USP drug classification [BR:br08302]
Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
Liothyronine
D01011 Liothyronine sodium (JP18/USP)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
243 Thyroid and parathyroid hormone preparations
2431 Thyroid hormones
D01011 Liothyronine sodium (JP18/USP)
Drug groups [BR:br08330]
Hormonal agent
DG01953 Thyroid preparation
DG01608 Thyroid hormone replenisher
DG01372 Liothyronine
D01011 Liothyronine sodium
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Thyroid hormone receptor (THR)
NR1A (THR)
D01011 Liothyronine sodium (JP18/USP) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01011 Liothyronine sodium
D01011 Liothyronine sodium tablets
Drug groups [BR:br08330]
Hormonal agent
DG01953 Thyroid preparation
DG01608 Thyroid hormone replenisher
DG01372 Liothyronine
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 24
1 C8y C 22.6938 -17.3834
2 O2a O 23.9120 -18.0919
3 C8y C 21.4993 -18.0919
4 C8y C 22.6938 -15.9897
5 C8y C 25.1241 -18.7889
6 C8x C 20.2754 -17.3834
7 X I 21.4993 -19.4857
8 C8x C 21.4993 -15.2870
9 X I 23.9120 -15.2870
10 C8x C 26.3421 -18.0919
11 C8x C 25.1241 -20.1884
12 C8y C 20.2754 -15.9897
13 C8y C 27.5543 -18.7889
14 C8x C 26.3421 -20.8911
15 C1b C 19.0632 -15.2870
16 C8y C 27.5543 -20.1884
17 X I 28.7605 -18.0919
18 C1c C 17.8453 -15.9897
19 O1a O 28.7605 -20.8911
20 C6a C 16.6331 -15.2870
21 N1a N 17.8453 -17.3834
22 O6a O 16.6331 -13.8875
23 O6a O 15.4149 -15.9897 #-
24 Z Na 13.6172 -13.9050 #+
BOND 24
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 3 6 1
6 3 7 1
7 4 8 2
8 4 9 1
9 5 10 1
10 5 11 2
11 6 12 2
12 10 13 2
13 11 14 1
14 12 15 1
15 13 16 1
16 13 17 1
17 15 18 1
18 16 19 1
19 18 20 1
20 18 21 1 #Down
21 20 22 2
22 20 23 1
23 8 12 1
24 14 16 2
|
|---|
